Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.

Autor: Braeuer RR; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zigler M, Villares GJ, Dobroff AS, Bar-Eli M
Jazyk: angličtina
Zdroj: Seminars in cancer biology [Semin Cancer Biol] 2011 Apr; Vol. 21 (2), pp. 83-8. Date of Electronic Publication: 2010 Dec 13.
DOI: 10.1016/j.semcancer.2010.12.007
Abstrakt: The molecular changes associated with the transition of melanoma cells from radial growth phase (RGP) to vertical growth phase (VGP) and the metastatic phenotype are not very well defined. However, some of the genes involved in this process and their transcriptional regulation are beginning to be elucidated. For example, the switch from RGP to VGP and the metastatic phenotype is associated with loss of the AP-2α transcription factor. AP-2α regulates the expression of c-KIT, MMP-2, VEGF, and the adhesion molecule MCAM/MUC18. Recently, we reported that AP-2α also regulates two G-protein coupled receptors (GPCRs) PAR-1 and PAFR. In turn, the thrombin receptor, PAR-1, regulates the expression of the gap junction protein Connexin-43 and the tumor suppressor gene Maspin. Activation of PAR-1 also leads to overexpression and secretion of proangiogenic factors such as IL-8, uPA, VEGF, PDGF, as well certain integrins. PAR-1 also cooperates with PAFR to regulate the expression of the MCAM/MUC18 via phosphorylation of CREB. The ligands for these GPCRs, thrombin and PAF, are secreted by stromal cells, emphasizing the importance of the tumor microenvironment in melanoma metastasis. The metastatic phenotype of melanoma is also associated with overexpression and function of CREB/ATF-1. Loss of AP-2α and overexpression of CREB/ATF-1 results in the overexpression of MCAM/MUC18 which by itself contributes to melanoma metastasis by regulating the inhibitor of DNA binding-1 (Id-1). CREB/ATF-1 also regulates the angiogenic factor CYR-61. Our recent data indicate that CREB/ATF-1 regulates the expression of AP-2α, thus, supporting the notion that CREB is an important "master switch" in melanoma progression.
(Copyright © 2010 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: